Progenity Return on Equity

Progenity (PROG) currently reports a ROE of 29.58%. That is above the Healthcare sector average of 21.18%. Use the charts on this page to explore Progenity's ROE history and peer comparisons.

Progenity's ROE of 29.58% is higher than the Healthcare sector average of 21.18%. That is roughly 39.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Progenity's current 29.58% should be judged against Healthcare norms (sector average: 21.18%) and against PROG's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 29.58%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.18%. From there, open related valuation or income-statement pages for Progenity, and consider following PROG for alerts when major investors trade the stock.

Progenity is classified in the Healthcare sector. On ROE, it currently shows 29.58% versus a sector average near 21.18%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PROG with unrelated industries.